Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quality of Life | 14 | 2023 | 499 | 1.990 |
Why?
|
| Ostomy | 11 | 2018 | 30 | 1.870 |
Why?
|
| Cancer Survivors | 7 | 2019 | 101 | 1.700 |
Why?
|
| Rectal Neoplasms | 10 | 2018 | 75 | 1.670 |
Why?
|
| Survivors | 8 | 2017 | 157 | 1.110 |
Why?
|
| Cystectomy | 2 | 2019 | 7 | 0.800 |
Why?
|
| Surveys and Questionnaires | 9 | 2019 | 1282 | 0.800 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2019 | 57 | 0.760 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 159 | 0.660 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 35 | 0.630 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 62 | 0.620 |
Why?
|
| Community Health Centers | 1 | 2019 | 64 | 0.610 |
Why?
|
| Guideline Adherence | 1 | 2019 | 149 | 0.590 |
Why?
|
| Humans | 38 | 2025 | 17314 | 0.560 |
Why?
|
| Self Care | 1 | 2018 | 144 | 0.530 |
Why?
|
| Female | 29 | 2023 | 12396 | 0.530 |
Why?
|
| Colorectal Neoplasms | 4 | 2018 | 622 | 0.500 |
Why?
|
| Male | 19 | 2023 | 9804 | 0.470 |
Why?
|
| Adult | 22 | 2022 | 7500 | 0.460 |
Why?
|
| Spirituality | 1 | 2013 | 2 | 0.410 |
Why?
|
| Middle Aged | 15 | 2020 | 7836 | 0.400 |
Why?
|
| Genetic Testing | 4 | 2024 | 69 | 0.370 |
Why?
|
| Premature Birth | 4 | 2020 | 132 | 0.370 |
Why?
|
| Decision Making | 3 | 2019 | 171 | 0.370 |
Why?
|
| Minority Groups | 2 | 2023 | 104 | 0.350 |
Why?
|
| Young Adult | 9 | 2019 | 2465 | 0.330 |
Why?
|
| Gynecology | 2 | 2020 | 22 | 0.320 |
Why?
|
| Pregnancy | 11 | 2020 | 1463 | 0.310 |
Why?
|
| Adolescent | 8 | 2023 | 3538 | 0.310 |
Why?
|
| Aged | 13 | 2019 | 6084 | 0.300 |
Why?
|
| Oregon | 6 | 2020 | 170 | 0.300 |
Why?
|
| Anastomosis, Surgical | 3 | 2017 | 10 | 0.270 |
Why?
|
| Long Term Adverse Effects | 2 | 2017 | 5 | 0.270 |
Why?
|
| Adaptation, Psychological | 2 | 2013 | 78 | 0.260 |
Why?
|
| Colectomy | 2 | 2016 | 31 | 0.250 |
Why?
|
| Washington | 5 | 2020 | 384 | 0.250 |
Why?
|
| Influenza, Human | 2 | 2020 | 282 | 0.250 |
Why?
|
| Genetic Counseling | 2 | 2023 | 27 | 0.250 |
Why?
|
| Social Justice | 1 | 2025 | 7 | 0.230 |
Why?
|
| Body Weight | 2 | 2016 | 203 | 0.230 |
Why?
|
| Genome, Human | 1 | 2025 | 34 | 0.230 |
Why?
|
| Weight Gain | 2 | 2016 | 156 | 0.220 |
Why?
|
| Prospective Studies | 3 | 2023 | 1226 | 0.220 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2023 | 6 | 0.210 |
Why?
|
| Delivery of Health Care | 2 | 2019 | 390 | 0.200 |
Why?
|
| Evidence-Based Medicine | 1 | 2024 | 169 | 0.200 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2019 | 46 | 0.200 |
Why?
|
| Child Health | 1 | 2023 | 39 | 0.200 |
Why?
|
| Gestational Age | 4 | 2016 | 112 | 0.200 |
Why?
|
| Infant, Premature | 2 | 2016 | 57 | 0.190 |
Why?
|
| Research Report | 1 | 2022 | 23 | 0.190 |
Why?
|
| Health Literacy | 1 | 2022 | 38 | 0.190 |
Why?
|
| Postpartum Period | 2 | 2013 | 79 | 0.190 |
Why?
|
| Quality Improvement | 1 | 2023 | 188 | 0.190 |
Why?
|
| Child | 3 | 2023 | 2403 | 0.170 |
Why?
|
| Urogenital System | 1 | 2020 | 2 | 0.170 |
Why?
|
| Vulvovaginitis | 1 | 2020 | 3 | 0.170 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2020 | 151 | 0.170 |
Why?
|
| Urologic Diseases | 1 | 2020 | 7 | 0.170 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2000 | 8 | 0.170 |
Why?
|
| Menopause | 1 | 2020 | 68 | 0.160 |
Why?
|
| Urinary Bladder | 1 | 2019 | 10 | 0.160 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 86 | 0.160 |
Why?
|
| Urinary Diversion | 1 | 2019 | 3 | 0.160 |
Why?
|
| Infant, Newborn | 6 | 2020 | 805 | 0.160 |
Why?
|
| Influenza Vaccines | 2 | 2020 | 292 | 0.160 |
Why?
|
| Child Development | 1 | 2020 | 53 | 0.160 |
Why?
|
| Self Report | 2 | 2018 | 257 | 0.150 |
Why?
|
| Socioeconomic Factors | 4 | 2013 | 605 | 0.150 |
Why?
|
| Thinness | 2 | 2016 | 31 | 0.150 |
Why?
|
| Child, Preschool | 1 | 2023 | 1380 | 0.150 |
Why?
|
| Pregnant Women | 1 | 2019 | 46 | 0.150 |
Why?
|
| Postoperative Complications | 2 | 2017 | 98 | 0.140 |
Why?
|
| Patient Selection | 1 | 2019 | 176 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 302 | 0.140 |
Why?
|
| Prenatal Care | 1 | 2019 | 127 | 0.140 |
Why?
|
| Research Design | 1 | 2019 | 336 | 0.140 |
Why?
|
| Primary Health Care | 2 | 2020 | 726 | 0.140 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 1925 | 0.140 |
Why?
|
| California | 3 | 2019 | 2311 | 0.140 |
Why?
|
| Employment | 1 | 2018 | 44 | 0.140 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 81 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2019 | 252 | 0.140 |
Why?
|
| Parents | 1 | 2000 | 297 | 0.130 |
Why?
|
| Blood Glucose | 1 | 2019 | 314 | 0.130 |
Why?
|
| Social Participation | 1 | 2017 | 3 | 0.130 |
Why?
|
| Defecation | 1 | 2017 | 6 | 0.130 |
Why?
|
| Rectum | 1 | 2017 | 13 | 0.130 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2016 | 12 | 0.130 |
Why?
|
| Ethnic Groups | 1 | 2019 | 451 | 0.130 |
Why?
|
| Recreation | 1 | 2017 | 39 | 0.130 |
Why?
|
| Organ Sparing Treatments | 1 | 2016 | 3 | 0.130 |
Why?
|
| Health Services | 2 | 2019 | 110 | 0.120 |
Why?
|
| Infant, Postmature | 1 | 2015 | 1 | 0.120 |
Why?
|
| Birth Certificates | 1 | 2015 | 24 | 0.120 |
Why?
|
| Health Status | 2 | 2018 | 293 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 381 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 27 | 0.120 |
Why?
|
| Body Mass Index | 3 | 2016 | 937 | 0.120 |
Why?
|
| Medical Records | 1 | 2015 | 91 | 0.120 |
Why?
|
| Sexual Behavior | 1 | 2016 | 128 | 0.120 |
Why?
|
| Pregnancy Complications | 2 | 2016 | 197 | 0.110 |
Why?
|
| Vaccination | 1 | 2019 | 688 | 0.110 |
Why?
|
| Mass Screening | 1 | 2019 | 672 | 0.100 |
Why?
|
| Diabetes, Gestational | 2 | 2019 | 311 | 0.100 |
Why?
|
| Fetal Macrosomia | 1 | 2013 | 27 | 0.100 |
Why?
|
| Pregnancy Outcome | 4 | 2016 | 158 | 0.100 |
Why?
|
| Sickness Impact Profile | 1 | 2013 | 25 | 0.100 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2013 | 54 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 355 | 0.100 |
Why?
|
| Infant Care | 1 | 2013 | 7 | 0.100 |
Why?
|
| Maternal Death | 1 | 2012 | 2 | 0.100 |
Why?
|
| Depression, Postpartum | 1 | 2013 | 22 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 2013 | 306 | 0.100 |
Why?
|
| Child Health Services | 1 | 2013 | 105 | 0.100 |
Why?
|
| Exercise | 1 | 2017 | 515 | 0.100 |
Why?
|
| Term Birth | 1 | 2012 | 9 | 0.100 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 1280 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2013 | 92 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2013 | 260 | 0.090 |
Why?
|
| Anxiety | 1 | 2013 | 154 | 0.090 |
Why?
|
| Social Support | 1 | 2013 | 207 | 0.090 |
Why?
|
| Prognosis | 3 | 2019 | 603 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 674 | 0.090 |
Why?
|
| Infant | 4 | 2020 | 1161 | 0.090 |
Why?
|
| Receptor, ErbB-2 | 1 | 2011 | 47 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 29 | 0.090 |
Why?
|
| Depression | 1 | 2015 | 486 | 0.090 |
Why?
|
| Risk Factors | 4 | 2023 | 3258 | 0.090 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2011 | 42 | 0.090 |
Why?
|
| Health Maintenance Organizations | 1 | 2012 | 407 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2019 | 2514 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 1151 | 0.070 |
Why?
|
| Length of Stay | 3 | 2013 | 171 | 0.070 |
Why?
|
| Anal Canal | 2 | 2017 | 9 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2019 | 2415 | 0.060 |
Why?
|
| United States | 3 | 2025 | 3866 | 0.060 |
Why?
|
| Glucose Tolerance Test | 2 | 2019 | 107 | 0.060 |
Why?
|
| Patient Preference | 2 | 2016 | 49 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 664 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 79 | 0.060 |
Why?
|
| Whole Genome Sequencing | 1 | 2024 | 10 | 0.060 |
Why?
|
| Incidental Findings | 1 | 2024 | 25 | 0.050 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2015 | 33 | 0.050 |
Why?
|
| Logistic Models | 2 | 2018 | 879 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 969 | 0.050 |
Why?
|
| Delivery, Obstetric | 2 | 2013 | 18 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2022 | 18 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 372 | 0.050 |
Why?
|
| Data Collection | 1 | 2022 | 238 | 0.050 |
Why?
|
| Communication | 1 | 2022 | 178 | 0.040 |
Why?
|
| Syndrome | 1 | 2020 | 28 | 0.040 |
Why?
|
| Vaccines, Inactivated | 1 | 2020 | 72 | 0.040 |
Why?
|
| Atrophy | 1 | 2019 | 6 | 0.040 |
Why?
|
| Attitude | 1 | 2019 | 28 | 0.040 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 17 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 43 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2019 | 57 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 191 | 0.040 |
Why?
|
| Volunteers | 1 | 2018 | 13 | 0.040 |
Why?
|
| Survivorship | 1 | 2018 | 12 | 0.040 |
Why?
|
| Hispanic Americans | 1 | 2019 | 375 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2019 | 476 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 17 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 26 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2016 | 38 | 0.030 |
Why?
|
| Health Surveys | 1 | 2016 | 245 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2015 | 92 | 0.030 |
Why?
|
| Focus Groups | 1 | 2015 | 143 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 252 | 0.030 |
Why?
|
| Disease Management | 1 | 2015 | 111 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2014 | 36 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 338 | 0.030 |
Why?
|
| Psychometrics | 1 | 2014 | 119 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 357 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 271 | 0.030 |
Why?
|
| Georgia | 1 | 2012 | 14 | 0.020 |
Why?
|
| Morbidity | 1 | 2012 | 59 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 270 | 0.020 |
Why?
|
| Medicaid | 1 | 2013 | 189 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2012 | 33 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 22 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 15 | 0.020 |
Why?
|
| Trastuzumab | 1 | 2011 | 19 | 0.020 |
Why?
|
| SEER Program | 1 | 2011 | 92 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 58 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2012 | 286 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1039 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2012 | 161 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 384 | 0.020 |
Why?
|
Concepts
(190)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->